EUVIMEDEUVIMED entdecken
Crossref

Molecular-Level Strategy from Bottom-Up to Acquire High-Efficiency Antimicrobial Peptides

Chu Wang, Jingyao Guo, Jiaming Zhang, Chenxi Hou, Yunmo Xue, Xiaofeng Han iD, Yan Chen, Mingxin Wang, Qian Ma iD, Xiaolin Lu iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c00567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Chu Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, Chin…. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Commission of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating threat of multidrug-resistant pathogens necessitates efficient antimicrobial development, in which antimicrobial peptides (AMPs) have been extensively studied due to their broad-spectrum antibiotic activity. Combining sum frequency generation and molecular dynamics simulation, we rationally designed AMPs by identifying two structural principles. Simply increasing the number of basic amino acids does not reliably improve antimicrobial efficacy; terminal (N' and C') phenylalanine residues can enhance AMP's membrane interfacial activity via the hydrophobic effect. After two rounds of sequence optimization, among the derivatives we designed, an artificial AMP named GF demonstrated superior membrane binding (especially insertion) and spatial conformation stability. In vitro and in vivo evaluations revealed GF's potential broad-spectrum efficacy against common bacteria and drug-resistant bacteria. Notably, GF exhibited enhanced antimicrobial potency over conventional antibiotics at lower concentrations. Our study established a bottom-up (mechanism-driven) design framework and provided a template for developing precision antimicrobials against resistant infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial PeptidesAnti-Bacterial AgentsMicrobial Sensitivity TestsMolecular Dynamics SimulationAnimalsStructure-Activity RelationshipDrug DesignHumans

Substanzen

Antimicrobial PeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
  • Department of General Dentistry, The Affiliated Stomatological Hospital of Nanjing Medical University; State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases; Jiangsu Province Engi…

ORCID-Profile: Xiaofeng Han, Qian Ma, Xiaolin Lu

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Commission of Health

Zitieren

APA

Wang, C., Guo, J., Zhang, J., Hou, C., Xue, Y., Han, X., Chen, Y., Wang, M., Ma, Q., & Lu, X. (2025). Molecular-Level Strategy from Bottom-Up to Acquire High-Efficiency Antimicrobial Peptides. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00567

Vancouver

Wang C, Guo J, Zhang J, Hou C, Xue Y, Han X, et al. Molecular-Level Strategy from Bottom-Up to Acquire High-Efficiency Antimicrobial Peptides. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00567

BibTeX
@article{Wang2025,
  author = {Wang, Chu and Guo, Jingyao and Zhang, Jiaming and Hou, Chenxi and Xue, Yunmo and Han, Xiaofeng and Chen, Yan and Wang, Mingxin and Ma, Qian and Lu, Xiaolin},
  title = {Molecular-Level Strategy from Bottom-Up to Acquire High-Efficiency Antimicrobial Peptides},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c00567}
}
Kostenlos starten →